Michael serves as a primary research and analytical resource for Innovations and its partners with a focus on market assessment of new medical technologies. Prior to joining the Clinic, he spent more than 11 years at Health Research International, an independent medical market research and consulting firm, most recently as Vice President. This experience entailed working closely with a broad range of medical technology firms from local start-ups to multinationals. Michael earned a BA in business administration (cum laude, Marketing major) from the Richard T. Farmer School of Business at Miami University.
Susan Bernat is responsible for the strategic planning, development and implementation of Communications, Marketing and Technology Systems Infrastructure & Integration for Cleveland Clinic Innovations. Susan is also responsible for the development and implementation of the annual Medical Innovation Summit. Prior to assuming this role in January 2014, Susan was the Director, Operations & Finance for CCI since November 2004. She was responsible for all fiduciary management including fiscal planning and other related financial activities. Susan also assists with establishing and implementing strategic goals and oversees long-range facilities planning. She served as the Director of Finance for the GCIC with responsibilities including development and implementation of strategy for ensuring financing of the GCIC consortium operations and management of financial performance and budgets. Prior to joining CCI, she was responsible for budget and contract negotiations within cardiology research at Cleveland Clinic. She received her undergraduate degree in Accounting from Kent State University, and an MBA from Cleveland State University.
Veronika’s function serves as liaison and administrative, technical, and operational resource for the Global Cardiovascular Innovation Center team. She has an extensive background providing support to senior-level Executives and world class service to all valued customers.
Phone: (216) 636-9952
Dr. Fortune serves as Senior General Manager, Cleveland Clinic Innovations. Prior to joining Cleveland Clinic, he was a Partner at Boston Millennia Partners, where he invested in early stage companies in pharmaceuticals and medical devices. Dr. Fortune has over 30 years of experience in the healthcare, life sciences and information technology sectors. He was previously President and Chief Operating Officer of New Era of Networks; Vice President at Monsanto; Vice President, at Bristol Myers Squibb;, Group President at Baxter International; and Vice President R&D at Baxter International. Dr. Fortune currently serves on the board of directors of Parexel International Corp, a global Contract
Research Organization as well as several private life sciences companies. He has been responsible for nurturing start-up activities from idea to prototype to standalone business. He has also been involved in some 30 M&A transactions from sourcing the company to closing the deal and successfully integrating the result. Pat has served on the engineering and scientific advisory boards of The University of Wisconsin, the University of Illinois, Cleveland Clinic, and the University of Chicago. Pat holds a BA from the University of Wisconsin, an MBA from Northwestern University, and a PhD in physical chemistry from the University of Wisconsin.
As a member of the Commercialization team, Kaleigh is the initial point of contact for Cleveland Clinic inventors who are considering the commercial potential of their inventions. In her current role, she advises inventors on the commercialization process and connects them with available resources. She works collaboratively with the Innovations team in the identification, marketing and commercialization of healthcare technologies. Kaleigh joins CCI with management experience in medical device sales. She received her BBA in Marketing, with a minor in Entrepreneurship, from the Richard T. Farmer School of Business at Miami University.
Phone: 216 444-0898
Mark Low comes to GCIC with a career of building successful programs to introduce new concepts and new modalities to new markets. He has managed all facets of product and market development spanning diagnostic and interventional cardiology, interventional radiology and neuroradiology, stroke treatment, image-guided surgery, drug delivery and oncology. He has served on the senior management team of TomTec Imaging Systems, Image Guided Technologies, EKOS Corporation, and Sonus Pharmaceuticals.
Prior to concentrating his focus on start-up ventures and early stage market development, Mr. Low held progressively more responsible and trailblazing positions in marketing and business development for Hewlett-Packard's Medical Products Group. Specializing in cardiovascular ultrasound, Mr. Low managed high performance cardiac diagnostic systems, introduced products to new market segments including private office and interventional cardiology, and developed new applications including 3D and stress echocardiography, and catheter-based intravascular ultrasound. In conjunction with these programs Mr. Low managed strategic relationships with various corporate partners, investors, universities, inventors, clinical investigators and manufacturers. Mr. Low received a B.A. degree in Natural Science from Johns Hopkins University, an M.S. degree in Physiology from the Medical College of Wisconsin, and an M.S. degree in Technical Communication from Rensselaer Polytechnic Institute.
Neema Mayhugh, PhD, has almost 20 years of experience in biotechnology business development. Prior to joining CCI, Neema was at Pfizer, Inc. where she managed market analytics for the worldwide Ophthalmology team. Before that she was in strategic consulting at the boutique healthcare consulting firm Easton Associates, which was later acquired by Navigant Consulting. Her doctoral research focused on understanding cell survival and death signaling pathways during apoptosis, or programmed cell death. While a research associate at Massachusetts General Hospital, Neema studied neurodegenerative signaling pathways.
Neema received her PhD in pharmacology & toxicology from Dartmouth College. She also has a BS in human physiology from Boston University.
Matt McBride has been with the Innovations group since 2012, focusing on the assessment, commercialization, and business development behind medical break-throughs at the Cleveland Clinic. Prior to joining CCI, Matt served as a Naval Officer at several commands throughout the world. As a Naval Officer he served as Executive Officer of the Military Sealift Command in Diego Garcia, Program Manager for the V-22 Osprey in Philadelphia, and as the Contract Administrator for Forward Operating Base, Camp Leatherneck, in Afghanistan.
Matt received a BS in political science with a focus on engineering, math and science in 2006, from the United States Naval Academy. Matt is currently pursuing his Executive MBA at Case Western Reserve University (2015).
Sonja O'Malley has over 20 years of experience in healthcare information technology. Prior to joining CCI, Sonja was responsible for managing the global life sciences client portfolio at Axentis. Axentis, a Wolters Kluwer business, is a software provider of on-demand solutions used by life science customers and other highly regulated industries to minimize their exposure to risk and optimize business performance; a $5 billion (2010) company with 19,000 employees worldwide. Sonja's work has spanned clinical laboratory medicine as a MT (ASCP), consulting in the health care practice of Andersen Consulting, directing the process improvement practice within a health insurance organization, and building multiple startups as an early employee.
Sonja is a certified PMP from the Project Management Institute and has a BS in medical technology from Miami University and an MBA from the Weatherhead School of Management at Case Western Reserve University.
Pete O’Neill has over 8 years of experience in CCI. Prior to joining CCI, Pete held positions as Deputy Director of the Great Lakes Industrial Technology Commercialization Center, and product engineer at PCC Airfoils. His main area of work at CCI is commercialization of medical devices, with particular focus on orthopaedic products.
Pete received his BS in aeronautical engineering from MIT.
Jason Ospina has over 10 years of experience in Life Sciences and over 2 years of experience in technology commercialization. Prior to joining CCI, Jason was a post-doctoral fellow at Cleveland Clinic's Lerner Research Institute. His research centered on the delineation of mechanisms regulating Hedgehog signal transduction and the influence of protein phosphorylation on pathway outcomes.
Jason received his PhD in genetics from Case Western Reserve University, where his thesis work examined nuclear protein dynamics and transport, as well as ribonucleoprotein biogenesis.
Marcie has over 10 years of experience in medical device product development and commercialization. Prior to joining CCI, Marcie held several product development positions at Kensey Nash Corporation in the fields of interventional cardiology and soft tissue repair, concluding as a Senior Biomaterials Engineer.
Marcie received her BS and MS in materials engineering from Drexel University.
Joe has almost a decade of technology commercialization experience, previously serving as a senior member of Cleveland Clinic’s New Venture group, and vice president and general counsel for The University of Akron Research Foundation, where he was instrumental in numerous corporate ventures and international deals.
Joe received his BS in biology from John Carroll University and his JD and MBA in finance from The University of Akron, where the Ohio governor appointed him to serve on the university's Board of Trustees.
Dhanesh Shah has over 6 years of experience in healthcare corporate finance, strategy and business development. Prior to joining CCI, Dhanesh worked in Division of Finance at Cleveland Clinic, overseeing Clinic’s debt capital portfolio. A strong background in economics and accounting, his past experience has been with financial services organizations focused on structured products ratings and financial auditing.
Dhanesh has received a BA in economics/accounting and his MS in accounting/taxation from University of Mumbai. He received an MBA from Case Western Reserve University.
Jon has over 7 years of healthcare experience including physician consulting, medtech marketing and market intelligence, and practice management. Prior to joining CCI, Jon was a Senior Consultant at SS&G Healthcare Services. His work centered on large-group physician management and organizational strategy, revenue cycle, and financial and productivity analytics. Prior to that, he worked at Health Research International, a leading medical device and diagnostics market intelligence and consulting firm.
Jon received his BS in mathematics and MA in English literature from John Carroll University.
Prior to joining the GCIC, Tom served as Executive Director of the Chamber of Commerce in Beachwood where he coordinated economic development efforts for the city. During his tenure, he helped more than 20 international companies establish their North America headquarters in Beachwood. Tom is committed to the Northeast Ohio community, having served as chair of the Northern Ohio Area Chambers of Commerce (NOACC). He is also a frequent guest columnist in publications such as Crain’s Cleveland Business, Inside Business and the Cleveland Jewish News. For his outstanding work, he has been recognized with awards from many economic development and community organizations. Tom was the Principal of TNS & Associates and prior to that served as a senior staff for academic institutions and social service organizations.
Tom received his BA from Kent State University and his MSW from the Wurzweiler School of Social Work.
Sarah has over 20 years in healthcare and is recognized for her expertise in practice management and strategic and business planning. Prior to rejoining CCF, Sarah worked as a Consultant at The Gateway Group, Vice President of Medical Operations at The MetroHealth System, and as an Administrator at CCF. Her work centered on directing and managing medical group practices, developing and executing strategic initiatives, front end revenue enhancement and improving the performance of existing product lines.
Sarah received her BS in business administration degree from John Carroll University and her MBA from Cleveland State University.
Charles Steiner has over 25 years of experience in medical technology development. Prior to joining CCI, Charles was a product development engineer for the Center for Neurological Restoration and a business and technology developer for the Center for Minimally Invasive Surgery at Cleveland Clinic. His contributions have been in the field of surgical navigation for cranial and spinal indications, neuromodulation for movement and cognitive indications as well as neuromodulation for headache and autonomic indications.
Charles received his BS in chemistry and computer science from Case Western Reserve University.
Mark serves as Science & Technology Innovation Officer at Cleveland Clinic Innovations as well as Associate Professor of Surgery (Urology) and Staff Urologist in the Cleveland Clinic Glickman Urological and Kidney Institute. Prior to joining CCF and CCF Innovations, Mark was an attending urologist at University Hospitals Case Medical Center where he served as Director of the Men's Health and Genitourinary Stone Center and Urology Institute Quality Officer as well as Chief of the Division of Urology and Medical Director for Urology Services at UH Richmond Medical Center.
Mark has an extensive business background in private equity and life science consulting as well as new venture development including transaction analysis and due diligence for health care, life science and biotechnology businesses. Mark’s private equity consulting experience includes transaction analysis for early stage, acquisition and add-on ventures.
Mark currently serves on the boards of the American Association of Clinical Urologists (AACU), the American Urological Association (AUA) North Central Section (NCS) and the Ohio Urological Society. Dr. Stovsky is currently President –Elect of the AACU and Treasurer-Elect of the NCS. He is Past President of the Cleveland Urological Society and the Ohio Urological Society as well as a past board member of the Academy of Medicine of Cleveland/Northern Ohio Medical Association. Dr. Stovsky recently completed the AUA Leadership Program (2012/2013 class). He has also been honored with selection to Best Doctors in America (2010 - present). Mark also serves on the boards of American Friends of Magen David Adom (Israel Red Cross) and Park Synagogue.
Dr. Stovsky earned undergraduate and medical degrees from Northwestern. He also holds an MBA (strategic planning) from the Katz Graduate School of Business at the University of Pittsburgh where he was elected to Beta Gamma Sigma. Dr. Stovsky completed his urology residency training at University Hospitals Case Medical Center in Cleveland, Ohio.
Phone: (216) 445-9039
Nisha Vagadia has over 14 years of experience in M&A and Biotechnology. Prior to joining CCI, Nisha was a Assoc. Director, Financial, Planning & Analysis (FP&A) at Acusphere. Previously she worked at Alkermes plc, PhaseForward and Arthur Andersen.
Nisha received her BS in business administration with a concentration in finance from University of Massachusetts at Amherst.
Neil is a Director with Cleveland Clinic Innovations. Neil primarily focuses on innovation management within both the Cleveland Clinic and its Healthcare Innovation Alliance Program. Neil has over 20 years of experience in biotechnology and technology commercialization. Prior to joining CCI, Neil Veloso was Senior Licensing Manager at the Case Western Reserve University Technology Transfer Office. There he sourced, negotiated and executed deals with pharmaceutical, medical device and diagnostic companies. Additionally, he was involved in medical imaging and pharmaceutical startup companies. At Athersys, his research and development work centered on process development of therapeutic proteins and small molecule drug screening.
Neil received a BA from the John Hopkins University, and MBA & MS from Case Western University.
Phone: 216-621-2234 ext. 110
Michael has over 10 years of experience in medical device marketing. Prior to joining CCI, Michael was a Senior Product Manager at Integra Lifesciences. His work centered on commercializing spine and neurosurgical related technologies. Michael received his BS in electrical engineering from Villanova University and his MBA from Case Western Reserve University.
Jim is a Director in Cleveland Clinic Innovations. Jim primarily focuses on working with outside entities on Business Engineering services. These services include identifying outside people/organizations in their early stages and working with them to address their organization’s needs as they progress through their incubation on their early commercial operations period. Service offerings include business diagnostics, market segmentation, introduction to the healthcare financial ecosystem, key opinion leader and subject matter expertise introduction and other services needed by early stage organizations. Jim has over 20 years of experience in healthcare operations and consulting services. Prior to joining CCI, Jim was the Institute Administrator for the Cleveland Clinic’s Orthopaedic and Rheumatologic Institute and Director of the Cleveland Clinic Innovation’s Enterprise Solutions team. His work centered on monetizing workflows, trade secrets and non-IP protectable solutions. Jim has also worked at finding solutions and introducing partners centered around healthcare solutions.
Jim received his BSBA in Finance from John Carroll University. He has an MBA from Cleveland State University and has his Series 6 and 63 securities license.
Matt has over 6 years of writing and marketing experience. Prior to joining CCI, he was a Grant Writer for LNE Group, where he consulted on funding opportunities for clients in healthcare, renewable energy, and manufacturing industries.
Matt received his BA in English from the University of Notre Dame.
Innovations has facilitated several Cleveland Clinic Spin-Offs over the last decade. Click here to see our current portfolio.
The Alliance network strives to realize new opportunities for innovation by gaining a 360-degree perspective on healthcare and its future.
Cleveland Clinic © 2014